215 related articles for article (PubMed ID: 11999818)
1. Efficacy of octreotide in the control of acute upper gastrointestinal bleeding.
Kullavanuaya P; Manotaya S; Thong-Ngam D; Mahachai V; Kladchareon N
J Med Assoc Thai; 2001 Dec; 84(12):1714-20. PubMed ID: 11999818
[TBL] [Abstract][Full Text] [Related]
2. Ranitidine versus ranitidine plus octreotide in the treatment of acute non-variceal upper gastrointestinal bleeding: a prospective randomised study.
Archimandritis A; Tsirantonaki M; Tryphonos M; Kourtesas D; Sougioultzis S; Papageorgiou A; Tzivras M
Curr Med Res Opin; 2000; 16(3):178-83. PubMed ID: 11191007
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized trial from Turkey comparing octreotide versus injection sclerotherapy in acute variceal bleeding.
Sivri B; Oksuzoglu G; Bayraktar Y; Kayhan B
Hepatogastroenterology; 2000; 47(31):168-73. PubMed ID: 10690604
[TBL] [Abstract][Full Text] [Related]
4. Sclerotherapy plus octreotide versus sclerotherapy alone in the management of gastro-oesophageal variceal hemorrhage.
Shah HA; Mumtaz K; Jafri W; Abid S; Hamid S; Ahmad A; Abbas Z
J Ayub Med Coll Abbottabad; 2005; 17(1):10-4. PubMed ID: 15929518
[TBL] [Abstract][Full Text] [Related]
5. Octreotide in acute bleeding esophageal varices: a prospective randomized study.
Freitas DS; Sofia C; Pontes JM; Gregório C; Cabral JP; Andrade P; Rosa A; Camacho E; Ferreira M; Portela F; Romãozinho JM; Tomé L; Gouveia H; Leitão M; Pimenta I; Donato A
Hepatogastroenterology; 2000; 47(35):1310-4. PubMed ID: 11100339
[TBL] [Abstract][Full Text] [Related]
6. Octreotide for esophageal variceal bleeding treated with endoscopic sclerotherapy: a randomized, placebo-controlled trial.
Morales GF; Pereira Lima JC; Hornos AP; Marques DL; Costa CS; Lima Pereira L; Lopes CV; Raymondi R; Marroni CA
Hepatogastroenterology; 2007; 54(73):195-200. PubMed ID: 17419259
[TBL] [Abstract][Full Text] [Related]
7. Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial.
D'Amico G; Politi F; Morabito A; D'Antoni A; Guerrera D; Giannuoli G; Traina M; Vizzini G; Pasta L; Pagliaro L
Hepatology; 1998 Nov; 28(5):1206-14. PubMed ID: 9794903
[TBL] [Abstract][Full Text] [Related]
8. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
Abid S; Jafri W; Hamid S; Salih M; Azam Z; Mumtaz K; Shah HA; Abbas Z
Am J Gastroenterol; 2009 Mar; 104(3):617-23. PubMed ID: 19223890
[TBL] [Abstract][Full Text] [Related]
9. [Octreotide in the treatment of acute gastrointestinal hemorrhage caused by ruptured esophageal varices].
Arfaoui D; Elloumi H; Ajmi S
Tunis Med; 2004 Oct; 82(10):947-50. PubMed ID: 15686191
[TBL] [Abstract][Full Text] [Related]
10. [Role of somatostatin in the management of upper gastrointestinal bleeding].
Herszényi L
Orv Hetil; 2002 May; 143(19 Suppl):1092-9. PubMed ID: 12063868
[TBL] [Abstract][Full Text] [Related]
11. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial.
Silvain C; Carpentier S; Sautereau D; Czernichow B; Métreau JM; Fort E; Ingrand P; Boyer J; Pillegand B; Doffël M
Hepatology; 1993 Jul; 18(1):61-5. PubMed ID: 8325622
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia.
Junquera F; Saperas E; Videla S; Feu F; Vilaseca J; Armengol JR; Bordas JM; Piqué JM; Malagelada JR
Am J Gastroenterol; 2007 Feb; 102(2):254-60. PubMed ID: 17311647
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic injection therapy for non-variceal upper gastrointestinal bleeding at Auckland Hospital.
Ogra R; Lane M; Wong P; Fraser A
N Z Med J; 2002 Nov; 115(1166):U255. PubMed ID: 12552274
[TBL] [Abstract][Full Text] [Related]
14. Prospective trial of endoscopic clips versus combination therapy in upper GI bleeding (PROTECCT--UGI bleeding).
Saltzman JR; Strate LL; Di Sena V; Huang C; Merrifield B; Ookubo R; Carr-Locke DL
Am J Gastroenterol; 2005 Jul; 100(7):1503-8. PubMed ID: 15984972
[TBL] [Abstract][Full Text] [Related]
15. [Does the antisecretory agent used affect the evolution of upper digestive hemorrhage?].
Ortí E; Canelles P; Quiles F; Zapater R; Cuquerella J; Ariete V; Tomé A; Medina E
Rev Esp Enferm Dig; 1995 Jun; 87(6):427-30. PubMed ID: 7612363
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of five days of subcutaneous octreotide treatment after sclerotherapy in preventing rebleeding from esophageal varices.
Yücesoy M; Başkol M; Keklik M; Güven M; Sungur M; Gürsoy S; Güven K; Ozbakir O
Turk J Gastroenterol; 2004 Sep; 15(3):137-43. PubMed ID: 15492910
[TBL] [Abstract][Full Text] [Related]
17. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis.
Khuroo MS; Khuroo MS; Farahat KL; Kagevi IE
J Gastroenterol Hepatol; 2005 Jan; 20(1):11-25. PubMed ID: 15610441
[TBL] [Abstract][Full Text] [Related]
18. Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.
Keyvani L; Murthy S; Leeson S; Targownik LE
Aliment Pharmacol Ther; 2006 Oct; 24(8):1247-55. PubMed ID: 17014584
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin infusion and hemodynamic changes in patients with non-variceal upper gastrointestinal bleeding: a pilot study.
Saruç M; Can M; Küçükmetin N; Tuzcuoglu I; Tarhan S; Göktan C; Yüceyar H
Med Sci Monit; 2003 Jul; 9(7):PI84-7. PubMed ID: 12883463
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin and ranitidine in the treatment of non-variceal upper gastrointestinal bleeding: a prospective, randomized, double-blind, controlled study.
Okan A; Simsek I; Akpinar H; Ellidokuz E; Sanul AR; Aksöz K
Hepatogastroenterology; 2000; 47(35):1325-7. PubMed ID: 11100343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
